10 results
Kawasaki Disease - Workup and Diagnostic Algorithm #Diagnosis #Management #Peds #Pediatrics #Kawasaki #Disease #Algorithm #CRASH #BURN
Kawasaki Disease ... #Diagnosis #Management ... #Peds #Pediatrics ... #Kawasaki #Disease ... #Algorithm #CRASH
Mucocutaneous Findings Kawasaki’s Disease - Patients present with diffuse red rash and fever with lymphadenopathy, strawberry
Mucocutaneous Findings Kawasaki ... with diffuse red rash ... #Clinical #Peds ... #Pediatrics #Kawasaki ... #Disease #Rash
Kawasaki Disease (KD) - Diagnosis and Management Summary

Kawasaki Disease (KD) is the most common vasculitis of
Conjunctivitis, Mucositis, Rash ... , Cough • +/-Nausea ... Polymorphous rash ... KD #vasculitis #rheumatology ... #pediatrics #diagnossi
Algorithm for the Evaluation of Kawasaki and Incomplete Kawasaki Disease:
Diagnosis
* Fever >5d
* Criteria (4/5)
  -
Algorithm for the ... , >1.5cm) - Rash ... criteria) #Diagnosis #Peds ... #Pediatrics #Kawasaki ... Criteria #Workup #Algorithm
Kawasaki Disease - Timeline of Clinical Features and Complications
 - Fever >5 days 
 - 4
Kawasaki Disease ... - Timeline of Clinical ... lymphadenopathy - Rash ... Signs #Symptoms #Peds ... #Pediatrics
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... 40, F:M 9:1 • Clinical ... Manifestations: Malar rash ... Positive in 60-80% of cases ... #Summary #rheumatology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... NPSLE rare, Malar rash ... Discontinuation of causal ... Manifestations: Malar rash ... comparison #table #rheumatology
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
erythematosus • Kawasaki ... Fever is the main clinical ... Petechial or purpuric rash ... Syndrome #Diagnosis #Management ... #Hematology #Rheumatology
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... NPSLE rare, Malar rash ... Discontinuation of causal ... DrugInduced #Lupus #DIL #rheumatology ... diagnosis #treatment #management
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
(blue-purple) rash ... • Erythematous rash ... auricular papules Clinical ... Muscle atrophy may cause ... #rheumatology #